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Thioredoxin-interacting protein (TXNIP) has multiple disease-associated functions including inducing
oxidative stress by inhibiting the anti-oxidant and thiol reducing activity of thioredoxin (TRX), reducing
cellular glucose transport, and is a component of the activated inflammasome complex. Increased
expression of TXNIP is encountered in diabetic conditions of high glucose. Curcumin and chemical de-
rivatives have multiple therapeutic properties as anti-inflammatories, anti-oxidants, amyloid aggregation
inhibitors and modulate a number of cellular signaling pathways. Using a fluorinated-derivative of
curcumin (designated Shiga-Y6), we showed significant inhibition of TXNIP mRNA and protein expres-
sion, and induction of TRX mRNA and protein in ARPE-19 retinal pigment epithelial cells and THP-1-
derived macrophages, while the non-fluorinated structural equivalent (Shiga-Y52) and native curcu-
min did not show these same effects. Shiga-Y6 was effective in reducing high glucose, endoplasmic
reticulum stress-induced TXNIP in ARPE-19 cells, and reducing lipopolysaccharide and endoplasmic
stress-induced proinflammatory gene expression in THP-1 macrophages. Moreover, TXNIP-knockdown
experiments showed that the anti-inflammatory effect of Shiga-Y6 in LPS-stimulated THP-1 macro-
phages was TXNIP-independent.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Oxidative stress is amajor feature ofmanydifferent degenerative
diseases and results from an imbalance in production of reactive
oxygen species (ROS) and deficits in cellular anti-oxidant systems.
Thioredoxin-interacting protein (TXNIP), also designated as
thioredoxin-binding protein-2 (TBP-2), an a-arrestin family mem-
ber, was identified as a vitamin D3-induced gene but recent findings
have indicated it is a central regulator of glucose homeostasis and
diabetes, and involved in vascular endothelial dysfunctions associ-
atedwith diabetes [1e3]. Increased levels of TXNIP promote cellular
oxidative stress by binding to the catalytic center of reduced thio-
redoxin (TRX), a significant cellular anti-oxidant protein, and
inhibiting its oxidant scavenging and thiol reducing activity [4].D.G. Walker), kinchan@belle.
Inc. This is an open access article u
al., Novel fluorinated derivat
macrophage cells, BiochemicaOxidative stress, inflammation and endoplasmic reticulum (ER)
stress are involved in the development of diabetes-related pathol-
ogies [5]. Increased expression of TXNIP occurs in conditions of high
glucose, which can result in pancreatic b cell apoptosis, the primary
cause of type-1 diabetes. TXNIP also functions as a tumor suppressor
and inhibits proliferation via activation of apoptosis signal regu-
lating kinase 1 (ASK1) [6]. Loss of TXNIP expression occurs in a
number of different cancers and correlates with poor outcome [7,8].
TXNIP is also directly involved in inflammatory activation through
its interaction with the nucleotide-binding domain, leucine-
richecontaining family, pyrin domainecontaining-3 (NLRP3)
inflammasomecomplex resulting in increasedprocaspase-1 activity
and interleukin-1 release [9]. Modulation of TXNIP expression and
activity is being investigated as a therapeutic strategy for diseases,
particularly those related to diabetes [2].
Curcumin is a polyphenolic compound derived from the curry
spice turmeric. The native compound and chemically-modified
derivatives have properties as anti-oxidants, anti-inflammatories,
anti-diabetes, anti-tumor agents and amyloid and tau aggregationnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ive of curcumin negatively regulates thioredoxin-interacting protein
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properties of curcumin and derivatives for treatment of diabetes
and Alzheimer’s disease are considered in recent reviews [10,11].
Multiple cellular signaling pathways in different cell types can be
affected by curcumin and related compounds, but at present due to
its low bioavailability in humans, native curcumin has shown
limited efficacy in vivo, and this has highlighted the need for
development of modified derivatives. We have produced a number
of curcumin derivatives based on their binding and inhibition of
aggregation of amyloid b peptides [12]. In addition, curcumin with
fluorine derivatives on the phenolic groups have proven useful as
ligands for magnetic resonance imaging (MRI) of Ab deposition in
animal models [13]. In this study, we investigated other biological
properties of curcumin and our novel derivatives. We report that a
fluorinated modified curcumin (designated Shiga-Y6) showed
significantly greater activity in inhibiting TXNIP expression and
enhancing TRX expression in cellular models of diabetes, endo-
plasmic reticulum stress and inflammation, while possessing the
anti-inflammatory properties of native curcumin. This agent may
have utility for treating oxidative stress and inflammation erelated
pathologies occurring in diabetes.
2. Materials and methods
2.1. Cell culture and reagents
The ARPE-19 retinal pigment epithelial (RPE) and THP-1 mono-
cytic leukemia cell lines were obtained from the American Type
Culture Collection (ATCC, Manassas, VA, U.S.A.). ARPE-19 cells were
cultured inDMEM/F12 (Nacalai-Tesque, Kyoto, Japan) supplemented
with 10% fetal bovine serum (FBS) and 50 mg/mL gentamicin. For
experimental purposes, cells were plated at 2.5  105 cells/well in
12-well plates. Cells were pretreated in media with 1% FBS with or
without curcumin (Wako Chemicals, Japan), Shiga-Y52 (SY52) or
Shiga-Y6 (SY6) for 2 h followed by these treatments: (1) 5 mM
glucose containing unmodified DMEM/F12 media (designated low
glucose e LG), or media supplemented with glucose to final con-
centrations of 25e100 mM (high glucose e HG); or (2) ER stress
inducer thapsigargin (TG) for 24 h (500 nMeARPE-19 cells; 300 nM
e THP-1 macrophages) treatments. Curcumin and derivatives were
maintained in media for the duration of all experiments. Shiga-Y52
(1,7-bis(40-hydroxy-30methoxy)phenyl 1,6- heptadiene-3,5-
dione) and Shiga-Y6 (1,7-bis(40-hydroxy-30trifluoromethoxy)
phenyl 1,6- heptadiene-3,5-dione) curcumin derivatives were
synthesized and purified in-house according tomodifications of our
published protocols [14]. Each reagent was dissolved in dimethyl
sulfoxide (DMSO) prior to dilution for use in experiments.
THP-1 monocytic cells were cultured in suspension using RPMI
1640 media supplemented with 10% FBS and gentamicin. For
experimental purposes, the cells were plated at 5 105 cells/well in
12-well plates in RPMI media with 1% FBS and exposed to 50 ng/mL
phorbolmyristate acetate (PMA) for 2 days to induce differentiation
to adherent macrophagedlike cells and then incubated with RPMI
media with 1% FBS for 24 h to allow functional recovery. THP-1-
derived macrophages were pretreated as described above with
curcumin and derivatives and then with lipopolysaccharide (LPS
from E. Coli 0157) for 6 h and 24 h, or TG (300 nM) for 24 h. Doses
were selected based on cell viability/toxicity results. After treat-
ments, cells were extracted for RNA or protein analysis, and culture
media collected for ELISA analysis.
2.2. Antibodies and immunoblot analyses
Antibodies to TXNIP, TRX and b-actin were obtained from
Abcam. Immunoblot analyses were carried out as previouslyPlease cite this article as: U. Buyandelger et al., Novel fluorinated derivat
expression in retinal pigment epithelial and macrophage cells, Biochemica
j.bbrc.2020.08.114described [15]. Due to the large separation in molecular weights,
most immunoblots for TXNIP and TRX were analyzed by combining
antibodies and detecting simultaneously but with different optimal
exposures for quantification.
2.3. TXNIP gene silencing by small interfering RNA (siRNA)
Differentiated THP-1 macrophages at 5  105 cells/well in 12-
well plates were transfected with 10 nmol/L TXNIP siRNA, sense
-50- GAAGAUCACCGAUUGGAGATT-3’; anti-sense -50- UCUC-
CAAUCGGUGAUCUUCAG-3’ (s20880; Ambion, MA, USA) or Stealth
RNAi negative control (Invitrogen, Medium GC, sequence not
available) using Lipofectamine RNAiMAX reagent (Invitrogen) ac-
cording to the manufacturer’s instruction. After transfection, some
cells were treated with TG (300 nM) or LPS (100 ng/mL) as
described above. TXNIP knockdown efficiency was evaluated by
real-time PCR and immunoblots.
2.4. Gene expression analysis
ARPE-19 and THP-1-derived macrophages were processed for
total RNA extraction using RNeasy-Plus Mini kit (Qiagen, Germany).
Complementary DNAs were prepared from total cellular RNA using
the PrimeScript RT kit with genomic DNA eraser (Takara Bio, Japan).
Quantitative PCR (qPCR) analysis of gene expression was carried
out using THUNDERBIRD SYBR Green qPCR Mix (Toyobo, Japan) as
previously described [15]. Gene specific primers used are listed in
Supplemental Table 1.
2.5. Enzyme-linked immunosorbent assay (ELISA)
The concentrations of chemokine ligand 2 (CCL2) and tumor
necrosis factor-a (TNF-a) were measured in supernatants of control
or treated cells using Human CCL2/MCP-1 (R&D Systems DY279)
and TNF-a (DY210) ELISA development kits.
2.6. Cell viability assay
Indices of cell viability were determined using a mitochondrial
activityWST-1 reagent (Cell Count Reagent; Nacalai-Tesque). Target
cells (ARPE-19 or THP-1) were plated at 5  104 cells/well in 96-
well microtiter plates. Cells were treated for 24 h with curcumin
and curcumin derivatives. Cell viability reagent (10 mL) was added
to each well for 4 h, and then the resulting color change measured
at 450 nm wavelength. Cell viability was calculated as percent
changes relative to DMSO-treated or control media-treated control
cells.
2.7. Measurement of intracellular reactive oxygen species (ROS)
Intracellular ROS was measured using the Cellular ROS Assay Kit
(ab113851, Abcam) according to the manufacturer’s protocol.
Briefly, ARPE-19 cells plated in 96 well-plates and treated with or
without 5 mM curcumin, Shiga-Y52 or Shiga-Y6 compounds in
mediumwith glucose (5 mM) or high glucose (25 mM) followed by
incubation with 25 mM 20,7’ edichlorofluorescin diacetate (DCFDA)
reagent for 45 min at 37 C prior to reading absorbance.
2.8. Statistical analysis
All experiments were performed in triplicate. All results are
expressed as mean ± S.E.M. Statistical analyses were performed
using GraphPad Prism 7 software. Experimental data were
analyzed by one-way ANOVA followed by Dunnet and Sidak’s test
of multiple comparisons between groups. p < 0.05 was consideredive of curcumin negatively regulates thioredoxin-interacting protein
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indicate p values: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****,
p < 0.0001.3. Results
3.1. Fluorinated curcumin derivative Shiga-Y6 reduced expression of
TXNIP and increased expression of TRX
Two experimental cellular models (ARPE-19 and THP-1) were
employed to investigate the effects of curcumin and two derivatives
on TXNIP and TRX expression, oxidative stress and inflammation
markers. We sought to determine if TXNIP was a key coordinating
factor for cellular responses and how this system was affected by
curcumin and our novel derivatives. The only differences between
SY6 and SY52 is the presence of fluorine atoms on the 30- methoxy
group in the phenol ring. Both compounds have an alkyl side chain
with carboxyl group at the C-4 position of curcumin (Fig. 1A).
Optimal doses of each agent were identified using a cell viability
assay. It was determined that a 5 mM dose for subsequent experi-
ments would allow comparison between compounds. The re-
sponses differed between cell types but at low dose a stimulating
effect was observed for the curcumin derivatives (ARPE-19 Fig. 1B;
THP-1 Fig. 1C). SY6 strongly inhibited expression of TXNIP mRNA
(Fig. 1D) and protein (Fig. 1E), while enhancing transcription of TRX
mRNA (Fig. 1F) and protein levels (Fig. 1G). Similar responses were
observed in both cell lines. Curcumin and SY52 did not significantly
affect TXNIP expression, but had a stimulating effect on TRX
expression (Fig. 1E, mRNA; Fig. 1G, protein), but with noticeablyFig. 1. Regulation of TXNIP and TRX expression by curcumin and derivatives in ARPE-19 ce
(A) Chemical structures of curcumin and derivatives SY52 and SY6. (B) Dose-response effec
macrophages. (DeG) Effects of curcumin and derivatives (5 mM dose) on TXNIP mRNA (D); o
19 cells and THP-1 macrophages (G). (H) Representative immunoblots for TXNIP and TRX
significance symbols as described in Methods.
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j.bbrc.2020.08.114reduced effects compared to SY6. Representative western blots are
shown for each cell type (ARPE-19 - Fig. 1H: THP-1 e Fig. 1I).3.2. Different effects of Shiga-Y6 on RPE cells between high glucose
and ER stress conditions
Using high glucose in media (25 mM, 50 mM and 100 mM
compared to 5 mM normal media glucose concentration (LG)), a
stimulating effect on mitochondrial activity measured in the cell
viability assay was observed in SY6 compared to curcumin-treated
ARPE-19 cells (Fig. 2A). High glucose treatments resulted in
reduced cell viability but there were no significant dose-dependent
differences between 25 mM, 50 mM and 100 mM doses. In sub-
sequent experiments, 25 mM dose was used as the high glucose
condition. As expected, high glucose resulted in significantly
increased levels of ROS, which was inhibited by curcumin but not
by SY6 treatment (Fig. 2B). Representative western blot panels for
TXNIP and TRX for both treatments are shown (Fig. 2CeD). SY6 was
effective at reducing high glucose mediated induction of TXNIP
mRNA (Fig. 2E) and protein (Fig. 2F), and inducing TRX mRNA
(Fig. 2G) and protein (Fig. 2H), while curcumin and SY52 were not.
Using a strong cellular ER stressor (TGe 500 nM), which induces ER
stress by blocking sarco/endoplasmic reticulum Ca2þ ATPase
(SERCA) activity resulting in higher intracellular calcium, increased
TXNIPmRNA (Fig. 2I) and protein (Fig. 2J), and increased TRXmRNA
(Fig. 2K) and protein (Fig. 2L) weremeasured. It was noticeable that
TG treatment alone strongly induced TXNIP and TRX expression,
while SY6 treatment strongly reversed TXNIP induction but further
induced TRX levels. These figures show that curcumin and SY52lls and THP-1 macrophages.
ts of curcumin and derivatives on cell viability of ARPE-19 cells and (C) THP-1-derived
n TXNIP protein levels (E); on TRX mRNA levels (F); and on TRX protein levels in ARPE-
in control and treated ARPE-19 cells and (I) THP-1 macrophages. Data analysis and
ive of curcumin negatively regulates thioredoxin-interacting protein
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Fig. 2. High glucose and ER stress induced expression of TXNIP and TRX significantly modulated by Shiga-Y6 curcumin derivative in ARPE-19 cells.
High Glucose: (A) Glucose dose-response (25 mM, 50 mM and 100 mM) compared to 5 mM (LG) effects on ARPE-19 cells in the presence of curcumin, SY52 and SY6 (5 mM) on cell
viability/mitochondrial activity assay. (B) Effect of curcumin and derivatives (5 mM) on high glucose (25 mM) induced reactive oxygen species (ROS) levels at different time-points.
(C) Representative immunoblots of TXNIP and TRX protein normalized with b-actin in cells treated with high glucose and curcumin or derivatives. (D) Representative immunoblots
of TXNIP and TRX protein normalized with b-actin in ARPE-19 cells treated with thapsigargin (TG), and curcumin or derivatives. SY6 significantly reduced high glucose induced
TXNIP mRNA (E) and TXNIP protein (F). SY6 significantly induced TRX mRNA (G) expression and protein (H) in the presence of high glucose.
ER stress: (I) SY6 significantly reduced TG (500 nM) induced TXNIP mRNA and protein (J) expression. SY6 significantly induced TRX mRNA (K) and protein (L) in the presence of TG
(500 nM).
U. Buyandelger et al. / Biochemical and Biophysical Research Communications xxx (xxxx) xxx4were ineffective or significantly less effective than SY6. By com-
parison, levels of secreted CCL2 and TNF-a from TG-treated cells
were reduced by all curcumin compounds (Supplemental Fig. 1).
3.3. Curcumin and derivatives inhibited expression of LPS and TG-
induced inflammatory genes
Comparison was made of the effects of curcumin and its de-
rivatives on inhibiting expression of inflammatory genes in LPS-
and TG-stimulated THP-1 macrophages. The stimulation of CCL2,
TNF-a and IL-1b expression was considerably higher using the
strong inflammogen LPS compared to the ER stress inducer TG. LPS
stimulation of CCL2 (Fig. 3A), TNF-a (Fig. 3C) and NLRP3 mRNA
(Fig. 3F) levels were highest at 6 h, while IL-1b mRNA (Fig. 3E) was
highest at 24 h. It can be seen that mRNA expression of all markers
and LPS stimulated secretion of CCL2 (Fig. 3B) and TNF-a (Fig. 3D)
were significantly inhibited by curcumin, SY52 and SY6. Overall,
these figures show that SY6 was generally more effective than the
other compounds in inhibiting mRNA or secreted protein for these
markers.
Comparing these results with TG-stimulated THP-1 macro-
phages, which has an inflammatory stimulating effect of a lowerPlease cite this article as: U. Buyandelger et al., Novel fluorinated derivat
expression in retinal pigment epithelial and macrophage cells, Biochemica
j.bbrc.2020.08.114magnitude than LPS, showed curcumin and SY6 had similar effec-
tiveness at reducing CCL2 mRNA (Fig. 3G) and secretion (Fig. 3H),
and TNF-a RNA (Fig. 3I) and secretion (Fig. 3J), while SY52 was less
effective. IL-1b mRNA expression was significantly inhibited by
curcumin, SY52 and SY6, with SY6 being more effective (Fig. 3K).
TG-stimulated expression of NLRP3 mRNA was only inhibited
significantly by SY6 (Fig. 3L). Levels of TXNIP and TRX with repre-
sentative immunoblot images for THP-1 macrophages treated with
TG and cell viability assay under experimental conditions are
shown in Supplemental Fig. 2.
3.4. TXNIP knockdown can result in enhanced expression of
inflammatory genes in THP-1 derived macrophages
To further investigate how TXNIP expression affected inflam-
matory activation in THP-1 macrophages, siRNA-mediated knock-
down of TXNIP expression was employed using cells treated with
LPS or TG with and without co-treatment with SY6. There was a
noticeable difference between responses by LPS- and TG-treated
cells. LPS stimulation did not alter TXNIP mRNA expression and
this was not significantly altered by cotreatment with SY6 (Fig. 4A).
The effectiveness of TXNIP mRNA knockdown was approximatelyive of curcumin negatively regulates thioredoxin-interacting protein
l and Biophysical Research Communications, https://doi.org/10.1016/
Fig. 3. Curcumin and derivatives reduced LPS and Thapsigargin induced inflammation in THP-1 derived macrophages.
LPS (AeF): Curcumin and derivatives reduced expression of CCL2 mRNA (A), CCL2 protein (B); TNF-a mRNA (C), TNF-a protein (D); IL-1b mRNA (E); NLRP3 mRNA (F) after 6 h and
24 h of LPS (100 ng/mL) stimulation. ER stress (GeL): Curcumin and derivatives reduced expression of CCL2 mRNA (G), CCL2 protein (H); TNF-a mRNA (I), TNF-a protein (J); IL-1b
mRNA (K); NLRP3 mRNA (L) after 24 h of treatment with TG (300 nM).
U. Buyandelger et al. / Biochemical and Biophysical Research Communications xxx (xxxx) xxx 590%. However, expression of CCL2 and TNF-a mRNA was signifi-
cantly increased in TXNIP knockdown cells (Fig. 4B and C). This
enhancement was greater in LPS stimulated cells. In these experi-
ments, CCL2 mRNA was significantly inhibited in LPS stimulated
cells by SY6 (Fig. 4B) while TNF-a RNA was not (Fig. 4C). However,
this pattern was not observed for control or LPS stimulated
expression of IL-1b (Fig. 4D) or NLRP3 (Fig. 4E). Silencing of TXNIP
mRNA had no significant effect on stimulated or unstimulated cells.
In contrast, using TG treated THP-1 macrophages, a different
pattern of gene expressionwas observed as a consequence of TXNIP
knockdown (Fig. 4FeJ). TG treated macrophages showed TXNIP
stimulated expression (Fig. 4F), whereas LPS stimulation did not
have this effect (Fig. 4A). TG stimulated expression of TXNIP was
inhibited by SY6 in control transfected cells but not TXNIP siRNA
transfected cells (Fig. 4F). CCL2 mRNA induction by TG was signif-
icantly reduced in TXNIP-silenced cells (Fig. 4G). This pattern was
also observed for IL-1b (Fig. 4I) and NLRP3 (Fig. 4J), however TNF-a
mRNA expression was not significantly different in TXNIP silenced
cells stimulated with TG compared to controls. Representative
western blot panels are shown for TXNIP protein in siRNA silenced
cells treated in the same manner (Supplemental Fig. 3).
4. Discussion
The major findings of this study are that our novel fluorinated
curcumin derivative SY6 significantly inhibited TXNIP expression inPlease cite this article as: U. Buyandelger et al., Novel fluorinated derivat
expression in retinal pigment epithelial and macrophage cells, Biochemica
j.bbrc.2020.08.114different cellular disease models; stimulated expression of the anti-
oxidant TRX; showed similar or increased anti-inflammatory ef-
fects of curcumin and derivatives in cellular models of inflamma-
tion and ER stress; and TXNIP silencing could result in enhanced
inflammation in LPS-stimulated macrophages but not TG treated
cells. It had been initially hypothesized that lowering TXNIP levels
would prevent the inhibitory binding to TRX, but the lowering of
TXNIP levels also had a transcription stimulating effect on TRX
expression. These studies point to the possible interactions of
signaling pathways. TXNIP transcription is induced by glucose-
stimulated translocation of the carbohydrate-response-element-
binding protein (ChREBP) to the nucleus and binding to the car-
bohydrate response element [16], while TXNIP expression is
negatively regulated by activation of AMP-activated protein kinase
(AMPK) [17,18]. Curcuminwas shown to inhibit gestational diabetes
partially through activation of AMPK [19]. Activation of AMPK can
result in increased expression of TRX as well as downregulated
TXNIP [20]. A recent in vitro study using WI-38 human lung fi-
broblasts showed curcumin had significant protective effects from
paraquat-induced toxicity by inhibiting TXNIP and NLRP3 expres-
sion and reducing inflammatory activity [21]. However, this study
employed curcumin doses of 300 mM, which was much larger than
thosewe demonstrated to have toxicity on ARPE-19 cells and THP-1
macrophages. The dose of 5 mM used in these experiments repre-
sents a reasonable physiological dose and showed significant effect
for SY6. In experiments presented in Figs. 3 and 4 with LPSive of curcumin negatively regulates thioredoxin-interacting protein
l and Biophysical Research Communications, https://doi.org/10.1016/
Fig. 4. TXNIP knockdown in THP-1-derived macrophage results in amplified inflammatory responses to LPS but not TG treatments.
TXNIP knockdown and LPS treatment. (A) siRNA knockdown of TXNIP mRNA was not affected by treatment with SY6, LPS or LPS and SY6. (B) TXNIP knockdown results in
significantly enhanced expression of CCL2 mRNA in control and LPS treated cells. (C) TXNIP knockdown results in significantly enhanced expression of TNF-a mRNA in control, LPS
and SY6-treated cells. (D) TXNIP knockdown did not result in enhanced expression of IL-1b mRNA. (E) TXNIP knockdown results in significantly enhanced expression of NLRP3
mRNA in control, LPS and SY6-treated cells.
TXNIP knockdown and TG treatment. (F) TXNIP mRNA expression in control and TXNIP knockdown cells. Comparison of effects of SY6, TG and SY6 and TG. (G) TXNIP knockdown
resulted in significant inhibition of CCL2 mRNA in TG treated THP-1 macrophages. (H) TXNIP knockdown did not result in significant inhibition of CCL2 mRNA in TG treated THP-1
macrophages and enhanced expression in TG and SY6 THP-1 macrophages. (IeJ) TXNIP knockdown resulted in significant inhibition of IL-1b (I) and NLRP3 mRNA (J) in TG treated
THP-1 macrophages.
U. Buyandelger et al. / Biochemical and Biophysical Research Communications xxx (xxxx) xxx6stimulation of macrophages, reduction in inflammatory gene
expression did not correlate with levels of TXNIP. Each curcumin
type was effective at reducing expression of CCL2, TNF-a, IL-1b and
NLRP3. This was confirmed with TG treated cells, though SY52 was
less effective than SY6. With LPS, the primary pathway for in-
flammatory activation is through NF-kB pathway, while TG induces
ER stress through raising intracellular calcium that can activate
different pathways. There was enhanced expression of CCL2 and IL-
1b, but not TNF-a, by LPS stimulated cells with TXNIP knockdown,
but these were reduced with TG treatment and TXNIP reduction.
Failures of glucose homeostasis leading to oxidative stress,
inflammation and endoplasmic reticulum stress due to type-1
diabetes with loss of pancreatic b cells or due to type-2 diabetes
with loss of insulin sensitivity are significant causes of morbidity.
Complications from diabetes include significant vascular endothe-
lial cell dysfunction linked to cardiovascular disease, cerebrovas-
cular disease, renal disease and loss of eyesight amongst others.
TXNIP has been linked to these conditions as a central regulator,
and as such becomes a target for therapeutics [1,22,23]. TXNIP
deficiency in experimental animal models was protective from the
consequences of diabetes [24]. TXNIP affects different cellular
functions not only facilitating oxidative stress through thioredoxin
inhibition. Dissecting the multiple mechanisms of TXNIP under
pathological conditions is inherently difficult, but identifying a
novel class of agents that affects TXNIP expression could be useful.
There has been much interest in curcumin and derivatives as theyPlease cite this article as: U. Buyandelger et al., Novel fluorinated derivat
expression in retinal pigment epithelial and macrophage cells, Biochemica
j.bbrc.2020.08.114can alleviate the consequences of diabetes-induced endothelial
dysfunction through reducing inflammation [25]. Curcumin com-
pounds can have different mechanisms of action as many different
signaling pathways can be downregulated, in particular NF-kB and
JNK [26], JAK/STAT/NF-kB [27] and PI3/AKT/mTOR [28].
In summary, these data indicate directions for future studies for
characterizing properties of curcumin derivatives. We have pro-
duced a number of different chemically modified curcumin de-
rivatives that can be tested in these simple assays for modulation of
TXNIP and TRX expression.Declaration of competing interest
The authors declare the following financial interests/personal
relationships which may be considered as potential competing
interests: Japanese patent application has been submitted
(#2020e141272) by the host institution (Shiga University of Med-
ical Science) covering the usage of the novel curcumin derivatives
Shiga-Y52 and Shiga-Y6. The intended patent application submis-
sion had no influence on the results presented in this publication.Acknowledgements
This work was supported by grant JP17H03560 to IT from the
Japan Society for the Promotion of Science.ive of curcumin negatively regulates thioredoxin-interacting protein
l and Biophysical Research Communications, https://doi.org/10.1016/
U. Buyandelger et al. / Biochemical and Biophysical Research Communications xxx (xxxx) xxx 7Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.bbrc.2020.08.114.
References
[1] H. Parikh, E. Carlsson, W.A. Chutkow, L.E. Johansson, et al., TXNIP regulates
peripheral glucose metabolism in humans, PLoS Med. 4 (2007) e158, https://
doi.org/10.1371/journal.pmed.0040158.
[2] D.Z. Wondafrash, A.T. Nire’a, G.G. Tafere, D.M. Desta, et al., Thioredoxin-
interacting protein as a novel potential therapeutic target in diabetes mellitus
and its underlying complications, Diabetes. Metab. Syndr. Obes. 13 (2020)
43e51, https://doi.org/10.2147/DMSO.S232221.
[3] J. Hu, Y. Yu, The function of thioredoxin-binding protein-2 (TBP-2) in different
diseases, Oxid. Med. Cell. Longev. (2018) 4582130, https://doi.org/10.1155/
2018/4582130, 2018.
[4] P.C. Schulze, J. Yoshioka, T. Takahashi, Z. He, et al., Hyperglycemia promotes
oxidative stress through inhibition of thioredoxin function by thioredoxin-
interacting protein, J. Biol. Chem. 279 (2004) 30369e30374, https://doi.org/
10.1074/jbc.M400549200.
[5] J. Lv, S. Bao, T. Liu, L. Wei, et al., Sulforaphane delays diabetes-induced retinal
photoreceptor cell degeneration, Cell Tissue Res. (2020), https://doi.org/
10.1007/s00441-020-03267-w.
[6] S. Matsuoka, H. Tsuchiya, T. Sakabe, Y. Watanabe, et al., Involvement of
thioredoxin-binding protein 2 in the antitumor activity of CD437, Canc. Sci. 99
(2008) 2485e2490, https://doi.org/10.1111/j.1349-7006.2008.00979.x.
[7] H. Shimizu, T. Tsubota, K. Kanki, G. Shiota, All-trans retinoic acid ameliorates
hepatic stellate cell activation via suppression of thioredoxin interacting
protein expression, J. Cell. Physiol. 233 (2018) 607e616, https://doi.org/
10.1002/jcp.25921.
[8] Y. Gao, J.-C. Qi, X. Li, J.-P. Sun, et al., Decreased expression of TXNIP predicts
poor prognosis in patients with clear cell renal cell carcinoma, Oncol. Lett. 19
(2020) 763e770, https://doi.org/10.3892/ol.2019.11165.
[9] X. Zhang, J.-H. Zhang, X.-Y. Chen, Q.-H. Hu, et al., Reactive oxygen species-
induced TXNIP drives fructose-mediated hepatic inflammation and lipid
accumulation through NLRP3 inflammasome activation, Antioxidants Redox
Signal. 22 (2015) 848e870, https://doi.org/10.1089/ars.2014.5868.
[10] S. Oliveira, T. Monteiro-Alfredo, S. Silva, P. Matafome, Curcumin derivatives
for Type 2 Diabetes management and prevention of complications, Arch
Pharm. Res. (Seoul) 43 (2020) 567e581, https://doi.org/10.1007/s12272-020-
01240-3.
[11] E. Chainoglou, D. Hadjipavlou-Litina, Curcumin in health and diseases: Alz-
heimer’s disease and curcumin analogues, derivatives, and hybrids, Int. J. Mol.
Sci. 21 (2020), https://doi.org/10.3390/ijms21061975.
[12] D. Yanagisawa, H. Taguchi, S. Morikawa, T. Kato, et al., Novel curcumin de-
rivatives as potent inhibitors of amyloid beta aggregation, Biochem. Biophys.
Reports. 4 (2015) 357e368, https://doi.org/10.1016/j.bbrep.2015.10.009.
[13] I. Tooyama, D. Yanagisawa, H. Taguchi, T.K. Kato, et al., Amyloid imaging using
fluorine-19 magnetic resonance imaging ((19)F-MRI), Ageing Res. Rev. 30
(2016) 85e94, https://doi.org/10.1016/j.arr.2015.12.008.Please cite this article as: U. Buyandelger et al., Novel fluorinated derivat
expression in retinal pigment epithelial and macrophage cells, Biochemica
j.bbrc.2020.08.114[14] H. Taguchi, D. Yanagisawa, S. Morikawa, K. Hirao, et al., Synthesis and
tautomerism of curcumin derivatives and related compounds, Aust. J. Chem.
68 (2015) 224e229.
[15] U. Buyandelger, D.G. Walker, D. Yanagisawa, T. Morimura, I. Tooyama, Effects
of FTMT expression by retinal pigment epithelial cells on features of angio-
genesis, Int. J. Mol. Sci. 21 (2020), https://doi.org/10.3390/ijms21103635.
[16] H. Cha-Molstad, G. Saxena, J. Chen, A. Shalev, Glucose-stimulated expression
of Txnip is mediated by carbohydrate response element-binding protein,
p300, and histone H4 acetylation in pancreatic beta cells, J. Biol. Chem. 284
(2009) 16898e16905, https://doi.org/10.1074/jbc.M109.010504.
[17] M. Shaked, M. Ketzinel-Gilad, E. Cerasi, N. Kaiser, G. Leibowitz, AMP-activated
protein kinase (AMPK) mediates nutrient regulation of thioredoxin-
interacting protein (TXNIP) in pancreatic beta-cells, PloS One 6 (2011),
e28804, https://doi.org/10.1371/journal.pone.0028804.
[18] J. Song, J. Li, F. Hou, X. Wang, B. Liu, Mangiferin inhibits endoplasmic reticulum
stress-associated thioredoxin-interacting protein/NLRP3 inflammasome acti-
vation with regulation of AMPK in endothelial cells, Metabolism 64 (2015)
428e437, https://doi.org/10.1016/j.metabol.2014.11.008.
[19] X. Lu, F. Wu, M. Jiang, X. Sun, G. Tian, Curcumin ameliorates gestational dia-
betes in mice partly through activating AMPK, Pharm. Biol. 57 (2019)
250e254, https://doi.org/10.1080/13880209.2019.1594311.
[20] X. Hou, J. Song, X.-N. Li, L. Zhang, et al., Metformin reduces intracellular
reactive oxygen species levels by upregulating expression of the antioxidant
thioredoxin via the AMPK-FOXO3 pathway, Biochem. Biophys. Res. Commun.
396 (2010) 199e205, https://doi.org/10.1016/j.bbrc.2010.04.017.
[21] Y. Ren, Z. Yang, Z. Sun, W. Zhang, et al., Curcumin relieves paraquat-induced
lung injury through inhibiting the thioredoxin interacting protein/NLR pyrin
domain containing 3-mediated inflammatory pathway, Mol. Med. Rep. 20
(2019) 5032e5040, https://doi.org/10.3892/mmr.2019.10612.
[22] L. Perrone, T.S. Devi, K.-I. Hosoya, T. Terasaki, L.P. Singh, Inhibition of TXNIP
expression in vivo blocks early pathologies of diabetic retinopathy, Cell Death
Dis. 1 (2010) e65, https://doi.org/10.1038/cddis.2010.42.
[23] A. Shah, L. Xia, H. Goldberg, K. W, et al., Thioredoxin-interacting protein
mediates high glucose-induced reactive oxygen species generation by mito-
chondria and the NADPH oxidase, Nox4, in mesangial cells, J. Biol. Chem. 288
(2013) 6835e6848, https://doi.org/10.1074/jbc.M112.419101.
[24] A. Shah, L. Xia, E.A.Y. Masson, C. Gui, et al., Thioredoxin-interacting protein
deficiency protects against diabetic nephropathy, J. Am. Soc. Nephrol. 26
(2015) 2963e2977, https://doi.org/10.1681/ASN.2014050528.
[25] N. Wongeakin, P. Bhattarakosol, S. Patumraj, Molecular mechanisms of cur-
cumin on diabetes-induced endothelial dysfunctions: txnip, ICAM-1, and
NOX2 expressions, BioMed Res. Int. 2014 (2014) 161346, https://doi.org/
10.1155/2014/161346.
[26] L. Qihui, D. Shuntian, Z. Xin, Y. Xiaoxia, C. Zhongpei, Protection of curcumin
against streptozocin-induced pancreatic cell destruction in T2D rats, Planta
Med. 86 (2020) 113e120, https://doi.org/10.1055/a-1046-1404.
[27] S. Geng, S. Wang, W. Zhu, C. Xie, et al., Curcumin suppresses JNK pathway to
attenuate BPA-induced insulin resistance in LO2 cells, Biomed. Pharmacother.
97 (2018) 1538e1543, https://doi.org/10.1016/j.biopha.2017.11.069.
[28] G.A. Borges, S.T. Elias, B. Amorim, C.L. de Lima, et al., Curcumin downregulates
the PI3K-AKT-mTOR pathway and inhibits growth and progression in head
and neck cancer cells, Phytother Res. (2020), https://doi.org/10.1002/ptr.6780.ive of curcumin negatively regulates thioredoxin-interacting protein
l and Biophysical Research Communications, https://doi.org/10.1016/
